Dr. Shulman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
Edison Clinic
222 W. 39th Ave
San Mateo, CA 94403- Is this information wrong?
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Infectious Disease, 1996 - 2000
University of ChicagoResidency, Internal Medicine, 1991 - 1995
University of Kansas School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1995 - 2025
IL State Medical License 1991 - 1996
Clinical Trials
- Maraviroc as an Immunomodulatory Drug for Antiretroviral-treated HIV Infected Patients Exhibiting Immunologic Failure Start of enrollment: 2008 Sep 01
Publications & Presentations
PubMed
- 21 citationsDynamic changes in innate immune responses during direct-acting antiviral therapy for HCV infection.Jacinta A. Holmes, Charles Carlton-Smith, Arthur Y. Kim, Emily O. Dumas, Joelle Brown, Jenna L. Gustafson, Georg M. Lauer, Sakuni T. Silva, Maxwell Robidoux, Daniel Kv...> ;Journal of Viral Hepatitis. 2019 Jan 3
- 15 citationsEfficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir in Patients With Hepatitis C Virus Genotype 1 or 4 Infection and Advanced Kidney Disease.Eric Lawitz, Edward Gane, Eric Cohen, John M. Vierling, Kosh Agarwal, Tarek Hassanein, Parvez S. Mantry, Paul J. Pockros, Michael B. Bennett, Nyingi Kemmer, Giuseppe M...> ;Kidney International Reports. 2019 Feb 1
- 2 citationsEfficacy and Safety of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir ± Ribavirin for HCV in Brazilian Adults with Advanced Fibrosis.Mario G. Pessoa, Jose Valdez Ramalho-Madruga, Katia Alves, Estevão P. Nunes, Hugo Cheinquer, Carlos Eduardo Brandão-Mello, Maria Cassia Mendes-Correa, Maria Lucia Gome...> ;Annals of Hepatology. 2018 Oct 16
- Join now to see all
Journal Articles
- inform \shulman, lancet
Press Mentions
Bluejay Therapeutics Advances in Hepatitis B and D Trials: Successfully Completes BJT-778 Phase 1a Study and Begins Phase 1b Trial EnrollmentJune 3rd, 2023
Grant Support
- Feasibility Of CCR5 Inhibitors In Preventing Maternal To Infant SIV TransmissionNational Center For Research Resources2009–2010
- Feasibility Of CCR5 Inhibitors In Preventing Maternal To Infant SIV TransmissionNational Institute Of Allergy And Infectious Diseases2008–2009
- Non-Nucleoside Reverse Transcriptive HypersensitivityNational Institute Of Allergy And Infectious Diseases2002–2006
Hospital Affiliations
- San Mateo Medical CenterSan Mateo, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
